Serum CA125 level as predictors of the efficacy of olaparib maintenance therapy for platinum-sensitive relapsed ovarian cancer.
J Obstet Gynaecol Res
; 49(12): 2883-2888, 2023 Dec.
Article
in En
| MEDLINE
| ID: mdl-37735981
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
Phthalazines
/
Piperazines
Type of study:
Diagnostic_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
Language:
En
Journal:
J Obstet Gynaecol Res
Journal subject:
GINECOLOGIA
/
OBSTETRICIA
Year:
2023
Document type:
Article
Affiliation country:
Japón
Country of publication:
Australia